Glaukos: Steep Premium For New Therapies And Growth (NYSE:GKOS)
· seekingalpha.com
Glaukos has the iDose TR, which moves it beyond surgical devices into sustained drug delivery. Read why I lean neutral on GKOS shares right now.
My name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, ...